Therefore, more in depth mechanistic studies are necessary to investigate the role of RIP1 in cancer cell necrosis, which will likely lead to potential new adjuvant cancer therapies for improving chemotherapy efficacy. This evidence concerns the gene RIPK1 and cancer.